SCHEMBL16634859

SCHEMBL16634859

N#Cc1ccc2c(c1)[nH]c(=O)n2-c1ccc(C(=O)O)cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.44
ALK Q9UM73 1/20 0.42
KDM4E B2RXH2 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NR3C2 P08235 1/20 0.39
TNKS O95271 4/20 0.39
TNKS2 Q9H2K2 2/20 0.39
PIN1 Q13526 1/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
HSP90AA1 P07900 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
CYP2C19 P33261 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20302464 0.82 L3MBTL1 (0.46) AURKAALKTNKS2PIN1MEN1
SCHEMBL16634626 0.81 HSP90AA1 (0.54) AURKAKDM4ESMN1; SMN2HSP90AA1CYP3A4
SCHEMBL16634724 0.77 TGFBR1 (0.47) AURKAKDM4ESMN1; SMN2TNKSCYP1A2
SCHEMBL16634734 0.72 DAO (0.50) AURKAKDM4ESMN1; SMN2CYP3A4CYP2C9
SCHEMBL31435021 0.72 MEN1 (0.62) KDM4ETNKSTNKS2MEN1KMT2A
SCHEMBL6840233 0.71 AURKA (0.52) AURKAKDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL3991350 0.71 PIN1 (0.44) TNKSTNKS2PIN1MAPT
SCHEMBL5434334 0.71 HSP90AA1 (0.65) TNKSTNKS2MEN1CYP1A2HSP90AA1
SCHEMBL16634719 0.70 AURKA (0.37) AURKAKDM4ESMN1; SMN2MEN1TSHR
SCHEMBL16634828 0.70 RORC (0.46) CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015052675-A1 SUBSTITUTED DIHYDRO-BENZIMIDAZOLE COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-04-16 WO disclosed